A feasibility study of accelerated BEP as first line chemotherapy for advanced germ cell tumours

Sponsor: Australia New Zealand Germ Cell Trials Group (ANZGCTG) ANZ Gynaecologic Oncology Group

Phase 2

Increased dose intensity BEP (3 or 4 cycles) for metastatic germ cell tumours

Brief Eligibility:  Open PDF summary

                          Consent and Patient Information

Status: Closed to recruitment

Initial screening tests: CT of chest, abdomen and pelvis

* Lung function test

* Bloods - FBC, Diff, EUC, LFTs, CMP, Glucose and tumour markers (AFP, B-HCG and LDH)

Contact: Raymond Tangunan  ph 9845 9564

Home